Abstract
This study aimed to characterize pharmacodynamic interaction between propofol and aminophylline. Nine beagle dogs were randomly allocated at the propofol rates of 0.75 (group A), 1.00 (group B), and 1.25 (group C) mg/kg/min. During period 1, propofol only was infused, while during period 2, aminophylline only, at the rate of 0.69 (group A), 1.37 (group B), and 2.62 (group C) mg/kg/h. During periods 3–5, the two drugs were co-administered. The aminophylline infusion rate was 0.69 (period 3), 1.37 (period 4), and 2.62 (period 5) mg/kg/h. The aminophylline was infused from 0 to 30 h, and the propofol was infused at 24 h for 20 min. Blood samples and electroencephalograms were obtained at preset intervals. In the linear regression between log-transformed doses of aminophylline and AUC inf , the slope was 0.6976 (95 % CI 0.5242–0.8710). Pharmacokinetics of aminophylline was best described by a one-compartment, with enzyme auto-induction, model. Pharmacokinetics and pharmacodynamics of propofol were best described by a three-compartment model and a sigmoid E max model, respectively. Pharmacodynamic parameter estimates of propofol were: k e0 = 0.805/min, E 0 = 0.76, E max = 0.398, Ce 50 na = 2.38 μg/mL (without aminophylline-exposure), Ce 50 wa = 4.49 μg/mL (with aminophylline-exposure), and γ = 2.21. Propofol becomes less potent when exposed to aminophylline. Pharmacodynamic antagonistic interaction of aminophylline with propofol sedation, may occur, not in a dose-dependent manner, but in an all-or-none response.
Similar content being viewed by others
References
Amabeoku GJ (1999) Gamma-aminobutyric acid and glutamic acid receptors may mediate theophylline-induced seizures in mice. Gen Pharmacol 32:365–372
Bruhn J, Bouillon TW, Hoeft A, Shafer SL (2002) Artifact robustness, inter- and intraindividual baseline stability, and rational EEG parameter selection. Anesthesiology 96:54–59
Carrasco G, Molina R, Costa J, Soler JM, Cabre L (1993) Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest 103:557–564
Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski W (1986) Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27:204–208
Efron B, Tibshirani R (1986) Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statist Sci 1:54–75
Favetta P, Degoute CS, Perdrix JP, Dufresne C, Boulieu R, Guitton J (2002) Propofol metabolites in man following propofol induction and maintenance. Br J Anaesth 88:653–658
Finer NN, Barrington KJ, Hayes B (1992) Prolonged periodic breathing: significance in sleep studies. Pediatrics 89:450–453
Hendeles L, Weinberger M (1983) Theophylline. A “state of the art” review. Pharmacotherapy 3:2–44
Hoegholm A, Steptoe P, Fogh B, Caldara A, Pedersen C (1989) Benzodiazepine antagonism by aminophylline. Acta Anaesthesiol Scand 33:164–166
Hooker AC, Staatz CE, Karlsson MO (2007) Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method. Pharm Res 24:2187–2197
Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB et al (2005) Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 8:858–859
Hupfl M, Schmatzer I, Buzath A, Burger H, Horauf K, Ihra G et al (2008) The effects of aminophylline on bispectral index during inhalational and total intravenous anaesthesia. Anaesthesia 63:583–587
Jenne JW, Nagasawa HT, Thompson RD (1976) Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 19:375–381
Jolley ME (1981) Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J Anal Toxicol 5:236–240
Kansaku F, Kumai T, Sasaki K, Yokozuka M, Shimizu M, Tateda T et al (2011) Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age. Drug Metab Pharmacokinet 26:532–537
Karlsson MO, Savic RM (2007) Diagnosing model diagnostics. Clin Pharmacol Ther 82:17–20
Kerbusch T, Huitema AD, Ouwerkerk J, Keizer HJ, Mathot RA, Schellens JH et al (2000) Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM. Br J Clin Pharmacol 49:555–561
Koizumi S, Saito K, Murashima YL, Kawakami Y (2010) Theophylline-induced changes in mouse electroencephalograms. Brain Dev 32:818–820
Krintel JJ, Wegmann F (1987) Aminophylline reduces the depth and duration of sedation with barbiturates. Acta Anaesthesiol Scand 31:352–354
Kulkarni C, Vaz J, David J, Joseph T (1995) Aminophylline alters pharmacokinetics of carbamazepine but not that of sodium valproate–a single dose pharmacokinetic study in human volunteers. Indian J Physiol Pharmacol 39:122–126
Lee EH, Lee SH, Park DY, Ki KH, Lee EK, Lee DH et al (2008) Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats. Anesthesiology 109:436–447
Lee SH, Ghim JL, Song MH, Choi HG, Choi BM, Lee HM et al (2009) Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs. Br J Pharmacol 158:1982–1995
Liguori MJ, Lee CH, Liu H, Ciurlionis R, Ditewig AC, Doktor S et al (2012) AhR activation underlies the CYP1A autoinduction by A-998679 in rats. Front Genet 3:213
Luszczki JJ, Jankiewicz K, Jankiewicz M, Czuczwar SJ (2007) Pharmacokinetic and pharmacodynamic interactions of aminophylline and topiramate in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol 562:53–59
Marrosu F, Marchi A, De Martino MR, Saba G, Gessa GL (1985) Aminophylline antagonizes diazepam-induced anesthesia and EEG changes in humans. Psychopharmacology 85:69–70
Mekhail-Ishak K, Lavoie PA, Sharkawi M (1987) Effects of caffeine and cyclic adenosine 3′,5′-monophosphate on adenosine triphosphate-dependent calcium uptake by lysed brain synaptosomes. Brain Res 426:62–68
Mengozzi G, Intorre L, Bertini S, Giorgi M, Soldani G (1998) Comparative bioavailability of two sustained-release theophylline formulations in the dog. Pharmacol Res 38:481–485
Mertens MJ, Olofsen E, Burm AG, Bovill JG, Vuyk J (2004) Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics. Anesthesiology 100:795–805
Morikawa A, Nishima S (2007) New Japanese pediatric guidelines for the treatment and management of bronchial asthma. Pediatr Int 49:1023–1031
Noh GJ, Kim KM, Jeong YB, Jeong SW, Yoon HS, Jeong SM et al (2006) Electroencephalographic approximate entropy changes in healthy volunteers during remifentanil infusion. Anesthesiology 104:921–932
Parke J, Holford NH, Charles BG (1999) A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 59:19–29
Pellegrino FC, Sica RE (2004) Canine electroencephalographic recording technique: findings in normal and epileptic dogs. Clin Neurophysiol 115:477–487
Rainnie DG, Grunze HC, McCarley RW, Greene RW (1994) Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 263:689–692
Rutherford JD, Vatner SF, Braunwald E (1981) Effects and mechanism of action of aminophylline on cardiac function and regional blood flow distribution in conscious dogs. Circulation 63:378–387
Sakurai S, Fukunaga A, Fukuda K, Kasahara M, Ichinohe T, Kaneko Y (2008) Aminophylline reversal of prolonged postoperative sedation induced by propofol. J Anesth 22:86–88
Self TH, Heilker GM, Alloway RR, Kelso TM, Abou-Shala N (1993) Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5–15 micrograms/mL. Pharmacotherapy 13:590–594
Shibata M, Wachi M, Kagawa M, Kojima J, Onodera K (2000) Acute and subacute toxicities of theophylline are directly reflected by its plasma concentration in dogs. Methods Find Exp Clin Pharmacol 22:173–178
Stirt JA (1983) Aminophylline may act as a morphine antagonist. Anaesthesia 38:275–278
Taylor BL, Collins C (1988) Aminophylline and propofol: apparent antagonism. Anaesthesia 43:508
Thakkar MM, Winston S, McCarley RW (2003) A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J Neurosci 23:4278–4287
Turan A, Memis D, Karamanlyodthlu B, Pamukcu Z, Sut N (2004) Effect of aminophylline on bispectral index. Acta Anaesthesiol Scand 48:408–411
Turan A, Kasuya Y, Govinda R, Obal D, Rauch S, Dalton JE et al (2010) The effect of aminophylline on loss of consciousness, bispectral index, propofol requirement, and minimum alveolar concentration of desflurane in volunteers. Anesth Analg 110:449–454
Wahlby U, Jonsson EN, Karlsson MO (2001) Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 28:231–252
Weinberger M, Hendeles L (1996) Theophylline in asthma. N Engl J Med 334:1380–1388
Yafune A, Ishiguro M (1999) Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: a use of bootstrap standard error. Stat Med 18:581–599
Zhu BT (2010) On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations. Expert Opin Drug Metab Toxicol 6:483–494
Acknowledgments
We are grateful to Ae-Kyung Hwang, B.S. (technician), Hyun-Jeong Park, B.S. (technician), and A-rum Kim, B.S. (technician) from the Clinical Research Center of Asan Medical Center (Seoul, Korea) for measuring plasma concentrations of propofol. This work was supported by the Student Research Grant (12-13) of University of Ulsan College of Medicine and Grant No. 2010-301 from the Asan Institute for Life Sciences, Seoul, Korea.
Author information
Authors and Affiliations
Corresponding author
Additional information
S-H. Lee and H-J. Kang contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lee, SH., Kang, HJ., Jin, SJ. et al. Impact of aminophylline on the pharmacodynamics of propofol in beagle dogs. J Pharmacokinet Pharmacodyn 41, 599–612 (2014). https://doi.org/10.1007/s10928-014-9377-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-014-9377-x